Trial intelligence / Profile preview

Dexmedetomidine during one-lung ventilation for thoracoscopic right lobectomy

ChiCTR2000031101Phase 4Not yet recruiting

Sponsor
Jiangsu Provincial People's Hospital
Start
Apr 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dexmedetomidine in bronchial carcinoma (2 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Arterial partial pressure of oxygen. Planned start Apr 2020; status: not yet recruiting.

02

Drugs

dexmedetomidine
03

Conditions

bronchial carcinoma

Beyond the preview

Go deeper on ChiCTR2000031101.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000031101.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call